One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Hippocampal Avoidance Prophylactic Cranial Irradiation: A New Standard of Care?.
Brown, Paul D. MD 1,,; Parsons, Michael W. PhD 2,; Rusthoven, Chad G. MD 3,; Gondi, Vinai MD 4,
doi : 10.1200/JCO.21.01632
Volume 39(28) pgs. 3093-3193 October 1, 2021
Optimizing Second-Line Therapy for Hodgkin Lymphoma: A Work in Progress.
Bartlett, Nancy L. MD 1,,
doi : 10.1200/JCO.21.01552
When Less Is More: Reevaluating the Role of Intensive Chemotherapy for Older Adults With Acute Myeloid Leukemia in the Modern Era.
Short, Nicholas J. MD 1,,; Kantarjian, Hagop MD 1,
doi : 10.1200/JCO.21.00960
Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma.
Moskowitz, Alison J. MD 1,,; Shah, Gunjan MD 2,; Schoder, Heiko MD 1; Ganesan, Nivetha MPH 1; Drill, Esther PhD 3; Hancock, Helen NP 1; Davey, Theresa PA 1; Perez, Leslie RN 1; Ryu, Sunyoung RN 1; Sohail, Samia MBS 1; Santarosa, Alayna MPH 1; Galasso, Natasha MSW 1; Neuman, Rachel MBA 1; Liotta, Brielle BS 1; Blouin, William MBA 1; Kumar, Anita MD 1,; Lahoud, Oscar MD 1,; Batlevi, Connie L. MD 1,; Hamlin, Paul MD 1,; Straus, David J. MD 1,; Rodriguez-Rivera, Ildefonso MD 1,; Owens, Colette MD 1; Caron, Philip MD 1,; Intlekofer, Andrew M. MD 1; Hamilton, Audrey MD 1; Horwitz, Steven M. MD 1,; Falchi, Lorenzo MD 1,; Joffe, Erel MD 1,; Johnson, William DO 1; Lee, Christina MD 1,; Palomba, M. Lia MD 1,; Noy, Ariela MD 1,; Matasar, Matthew J. MD 1,; Pongas, Georgios MD 4,; Salles, Gilles MD 1,; Vardhana, Santosha MD 1,; Sanin, Beatriz Wills MD 1; von Keudell, Gottfried MD 1,; Yahalom, Joachim MD 1; Dogan, Ahmet MD 1,; Zelenetz, Andrew D. MD 1,; Moskowitz, Craig H. MD 4,
doi : 10.1200/JCO.21.01056
Randomized Phase III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small-Cell Lung Cancer (PREMER): A GICOR-GOECP-SEOR Study.
Rodriguez de Dios, Nuria MD, PhD 1,2,3,,; Counago, Felipe MD, PhD 4,; Murcia-Mejia, Mauricio MD 5; Rico-Oses, Mikel MD, PhD 6; Calvo-Crespo, Patricia MD 7; Samper, Pilar MD 8; Vallejo, Carmen MD, PhD 9; Luna, Javier MD 10; Trueba, Itziar MD 11; Sotoca, Amalia MD 12; Cigarral, Cristina MD 13; Farre, Nuria MD 14; Manero, Rosa M. Psy 15; Duran, Xavier MStat, PhD 2; Gispert, Juan Domigo MD, PhD 2,3,16,17,; Sanchez-Benavides, Gonzalo PhD 2,16,18; Rognoni, Teresa Psy 19; Torrente, Margarita PhD 20,21; Capellades, Jaume MD 22,; Jimenez, Mar MD 23; Cabada, Teresa MD, PhD 24; Blanco, Miguel MD 25; Alonso, Ana MD 26; Martinez-San Millan, Juan MD 27; Escribano, Jose MD 28; Gonzalez, Beatriz Psy 13; Lopez-Guerra, Jose Luis MD, PhD 29
doi : 10.1200/JCO.21.00639
Avapritinib Versus Regorafenib in Locally Advanced Unresectable or Metastatic GI Stromal Tumor: A Randomized, Open-Label Phase III Study.
Kang, Yoon-Koo MD, PhD 1,; George, Suzanne MD 2,; Jones, Robin L. MD 3,; Rutkowski, Piotr MD, PhD 4,; Shen, Lin MD, PhD 5; Mir, Olivier MD, PhD, MPH 6,; Patel, Shreyaskumar MD 7,; Zhou, Yongjian MD, PhD 8; von Mehren, Margaret MD 9,; Hohenberger, Peter MD 10,; Villalobos, Victor MD, PhD 11,12,; Brahmi, Mehdi MD 13,; Tap, William D. MD 14,; Trent, Jonathan MD, PhD 15,; Pantaleo, Maria A. MD, PhD 16; Schoffski, Patrick MD 17,; He, Kevin PhD 18,; Hew, Paggy MS 18,; Newberry, Kate PhD 18,; Roche, Maria MS 18,; Heinrich, Michael C. MD 19,; Bauer, Sebastian MD 20,,
doi : 10.1200/JCO.21.00217
Phase II Study of Gemcitabine and Split-Dose Cisplatin Plus Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Bladder Cancer.
Rose, Tracy L. MD, MPH 1,2,; Harrison, Michael R. MD 3,; Deal, Allison M. MS 1; Ramalingam, Sundhar MD 3,; Whang, Young E. MD 1,2,; Brower, Blaine FNP 2,; Dunn, Mary MSN, NP-C 2,4; Osterman, Chelsea K. MD 2; Heiling, Hillary M. MS 1; Bjurlin, Marc A. MD 1,4,; Smith, Angela B. MD 1,4,; Nielsen, Matthew E. MD 1,4,; Tan, Hung-Jui MD 1,4; Wallen, Eric MD 1,4,; Woods, Michael E. MD 1,5; George, Daniel MD 3,; Zhang, Tian MD 3,; Drier, Anthony BS 1,; Kim, William Y. MD 1,2,; Milowsky, Matthew I. MD 1,2,,
doi : 10.1200/JCO.21.01003
Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric KMT2A-Rearranged AML: Results From the Phase III Children's Oncology Group Trial AAML0531.
Pollard, Jessica A. MD 1,2,,; Guest, Erin MD 3,; Alonzo, Todd A. PhD 4,5; Gerbing, Robert B. MS 5; Loken, Mike R. PhD 6,; Brodersen, Lisa Eidenschink PhD 6,; Kolb, E. Anders MD 7,; Aplenc, Richard MD, PhD 8; Meshinchi, Soheil MD, PhD 9,10; Raimondi, Susana C. PhD 11; Hirsch, Betsy PhD 12; Gamis, Alan S. MD 3,
doi : 10.1200/JCO.20.03048
Arsenic Combined With All-Trans Retinoic Acid for Pediatric Acute Promyelocytic Leukemia: Report From the CCLG-APL2016 Protocol Study.
Zheng, Huyong MD, PhD 1,2,3,4; Jiang, Hui MD 5; Hu, Shaoyan MD 6; Liao, Ning MD 7; Shen, Diying MD 8; Tian, Xin MD 9; Hao, Guoping MD 10; Jin, Runming MD 11; Li, Jianxin MD 12; Fang, Yongjun MD 13; Ju, Xiuli MD 14; Liu, Ansheng MD 15; Wang, Ningling MD 16; Zhai, Xiaowen MD 17; Zhu, Jiashi MD 5; Hu, Qun MD 18; Li, Limin MD 19; Liu, Wei MD 20; Sun, Lirong MD 21; Wang, Li MD 22; Dai, Yunpeng MD 23; Feng, Xiaoqin MD 24; Li, Fu MD 25; Liang, Hui MD 26; Luo, Xinhui MD 27; Yan, Mei MD 28; Yin, Qingning MD 29; Chen, Yan MD 30; Han, Yueqin MD 31; Qu, Lijun MD 32; Tao, Yanling MD 33; Gao, Hui MD 34; He, Zhixu MD 35; Lin, Limin MD 36; Luo, Jixia MD 37; Pan, Kaili MD 38; Zhang, Jingrong MD 39; Zhang, Rong MD 40; Zhou, Min MD 41; Zhang, Yuanyuan MD 1,2,3,4; Wang, Linya MD 1,2,3,4; Zhang, Ruidong MD 1,2,3,4; Xiao, Peifang MD 6; Ling, Yayun MD 7; Peng, Xiaoxia MD 42; Peng, Yaguang MD 42; Wang, Tianyou MD 1,2,3,4,; for the Chinese Children's Leukemia Group
doi : 10.1200/JCO.20.03096
E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor-Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research Group.
Connolly, Roisin M. MB, BCh, MD 1,2,,; Zhao, Fengmin MS, PhD 3; Miller, Kathy D. MD 4,; Lee, Min-Jung PhD 5; Piekarz, Richard L. MD, PhD 6; Smith, Karen L. MD 1,; Brown-Glaberman, Ursa A. MD 7,; Winn, Jennifer S. MD 8; Faller, Bryan A. MD 9,; Onitilo, Adedayo A. MD, PhD 10,; Burkard, Mark E. MD 11,; Budd, George T. MD 12,; Levine, Ellis G. MD 13,; Royce, Melanie E. MD, PhD 14; Kaufman, Peter A. MD 15,; Thomas, Alexandra MD 16,; Trepel, Jane B. PhD 5,; Wolff, Antonio C. MD 1,; Sparano, Joseph A. MD 17,
doi : 10.1200/JCO.21.00944
Immunotherapy in Patients With Locally Advanced Esophageal Carcinoma: ASCO Treatment of Locally Advanced Esophageal Carcinoma Guideline Rapid Recommendation Update.
Shah, Manish A. MD 1,; Hofstetter, Wayne L. MD 2; Kennedy, Erin B. MHSc 3; for the Locally Advanced Esophageal Carcinoma Guideline Expert Panel
doi : 10.1200/JCO.21.01831
How Can Documentation of Caregivers Offer More Than One-Way Care by Health Care Professionals?.
Ishida, Mayumi CP, PhD; Onishi, Hideki MD, PhD
doi : 10.1200/JCO.21.01382
Reply to M. Ishida et al.
Applebaum, Allison J. PhD; Kent, Erin E. PhD; Lichtenthal, Wendy G. PhD
doi : 10.1200/JCO.21.01618
The Best Surgery Should Be Applied for Locally Advanced Esophageal Cancer.
Li, Bin MD; Chen, Haiquan MD
doi : 10.1200/JCO.21.01340
Reply to B. Li et al.
Eyck, Ben M. MD; Wijnhoven, Bas P. L. MD, PhD; van Lanschot, J. Jan B. MD, PhD
doi : 10.1200/JCO.21.01543
